A Comprehensive Portfolio of Success
DMTI has been providing Contract Manufacturing for Marrow Access Technologies since 2019. Their cutting-edge device is the latest first-line treatment for getting patients with cartilage defects back in action.
DMTI has been providing Contract Manufacturing for Mahe Medical USA since 2020. Their newest device, the Xtracta-Screw, is the latest first-line screw extraction device that alleviates the need for further sterilization after use of the single product.
Tested & Proven
Medical Manufacturing Excellence
As we realized the desire of hospitals and ambulatory surgical centers (ASC) to work directly with the manufacturers of their implantable devices, it was clear there was a massive gap in the market, that, with the right infrastructure and expertise, DMTI could fill. Additionally, we are continuing our sales partnership with Mahe Medical. We can help clients develop, manufacturer, test, and sterilize; with a proven sales outlet already in place. It’s a great win-win-win scenario. To do that we are focusing the company in the Orthopedic surgical world. The focus is on trauma and then will move into nails and joints (hips, knee, and spine) as we grow. We have visions for a full-service sterilization and medical training operations that will round out our new Center for Medical Manufacturing Excellence.
[Laramie, Wyoming – A second CARES Act grant has been received by Disruptive MedTech (DMTI through the Wyoming Business Council. The $28,000 grant is part of the Wyoming business relief funds approved by Governor Mark Gordon and the Wyoming Legislature. The state is...
Laramie, Wyoming – Disruptive MedTech (DMTI) announced the hiring of Jennifer Petersen. Petersen will serve as the company’s Controller/CFO and HR Director. She will support the development of DMTI’s pitch deck, fundraising, and financial models. Petersen most...